Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese

Endocrine Journal

Volumn 60, Issue 11, 2013, Pages 1215-1220

  He, Jinshan ^a,b   Wang, Jingcheng ^a   Wang, Daxin ^a   Dai, Shanhe ^a   Yv, Tangyun ^a   Chen, Pengtao ^a   Ma, Renshi ^a   Diao, Chunyv ^a   Lv, Guohua ^b  

^a YANGZHOU UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Genetic variants; MDM2 gene; Molecular markers; Osteosarcoma; Susceptibility

Indexed keywords

PROTEIN MDM2;

AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MDM2 GENE; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; YOUNG ADULT;

EID: 84888424566     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0260     Document Type: Article

References (26)

1. Dorfman HD, Czerniak B (1995) Bone cancers. Cancer 75: 203-210.
2. Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115: 1531-1543.
3. Hameed M, Dorfman H (2011) Primary malignant bone tumors-recent developments. Semin Diagn Pathol 28: 86-101.
4. Wang LL (2005) Biology of osteogenic sarcoma. Cancer J 11: 294-305.
5. Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, Teshome K, Uzoka A, Douglass C, Hayes RB, Hoover RN, Savage SA (2010) Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis 31: 1400-1404.
6. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, Malawer MM (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65: 1123-1132.
7. Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jurgens H, Gadner H, Bielack SS (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21: 2011-2018.
8. Ries LAG and SEER Program (National Cancer Institute (U.S.). (1999) Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 /[edited by Lynn A. Gloecker Ries. et al.]. National Cancer Institute, SEER Program, Bethesda, MD. http://seer.cancer.gov/publications/childhood/
9. Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ (2007) Analysis of genes critical for growth regulation identifies Insulinlike Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16: 1667-1674.
10. Fuchs B, Zhang K, Schabel A, Bolander ME, Sarkar G (2001) Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene 278: 245-252.
11. Salinas-Souza C, Petrilli AS, de Toledo SR (2010) Glutathione S-transferase polymorphisms in osteosarcoma patients. Pharmacogenet Genomics 20: 507-515.
12. Wang W, Wang J, Song H, Liu J, Song B, Cao X (2011) Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma. Genet Test Mol Biomarkers 15: 503-506.
13. Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, Song W, Yuan W (2011) Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol 30: 1051-1055.
14. Liu Y, Lv B, He Z, Zhou Y, Han C, Shi G, Gao R, Wang C, Yang L, Song H, Yuan W (2012) Lysyl oxidase polymorphisms and susceptibility to osteosarcoma. PLoS One 7: e41610.
15. Caronia D, Patino-Garcia A, Perez-Martinez A, Pita G, Moreno LT, Zalacain-Diez M, Molina B, Colmenero I, Sierrasesumaga L, Benitez J, Gonzalez-Neira A (2011) Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One 6: e26091.
16. Toffoli G, Biason P, Russo A, De Mattia E, Cecchin E, Hattinger CM, Pasello M, Alberghini M, Ferrari C, Scotlandi K, Picci P, Serra M (2009) Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin Cancer Res 15: 3550-3556.
17. Mirabello L, Yu K, Berndt SI, Burdett L, Wang Z, Chowdhury S, Teshome K, Uzoka A, Hutchinson A, Grotmol T, Douglass C, Hayes RB, Hoover RN, Savage SA (2011) A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 11: 209.
18. Cai X, Yang M (2012) The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis. J Cancer Res Clin Oncol 138: 555-561.
19. Naumov VA, Generozov EV, Solovyov YN, Aliev MD, Kushlinsky NE (2012) Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors. Bull Exp Biol Med 153: 869-873.
20. Wunder JS, Eppert K, Burrow SR, Gokgoz N, Bell RS, Andrulis IL (1999) Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 18: 783-788.
21. Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL (2010) Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Genes Chromosomes Cancer 49: 518-525.
22. Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A (1989) Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17: 3606.
23. Yuan ZR, Li J, Li JY, Gao X, Xu SZ (2013) SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep 40: 7-12.
24. Yuan ZR, Li JY, Li J, Zhang LP, Gao X, Gao HJ, Xu SZ (2012) Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene 505: 190-194.
25. Yuan ZR, Li JY, Li J, Gao X, Xu SZ (2013) Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep 40: 1947-1954.
26. Zhao CJ, Li N, Deng XM (2003) The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan 25: 327-329.